Company announcement 06/2023.

Roskilde, September 27. 2023

We are thrilled to announce the decission by the European Patent Office to grant Apillet a European Patent with the title Novel Oral Composition. The decision will take effect on October 4. 2023, when the mention of the grant is published in the European Patent Bulletin 23/40.

We are happy that the IP rights for Apillets groundbreaking encapsulation technology behind our APIVault and NeutraValt lines of gastro-resistant enteric encapsulation for biopharmaceuticals and nutraceuticals are now starting to be secured on national levels.